These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 27387385)

  • 21. Safety and Outcome of Decompressive Hemicraniectomy After Recombinant Tissue Plasminogen Activator Thrombolysis for Acute Ischemic Stroke: A Systematic Review.
    Pedro KM; Roberto KT; Chua AE
    World Neurosurg; 2020 Dec; 144():50-58. PubMed ID: 32822948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II).
    Larrue V; von Kummer R R; Müller A; Bluhmki E
    Stroke; 2001 Feb; 32(2):438-41. PubMed ID: 11157179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic review of outcome after ischemic stroke due to anterior circulation occlusion treated with intravenous, intra-arterial, or combined intravenous+intra-arterial thrombolysis.
    Mullen MT; Pisapia JM; Tilwa S; Messé SR; Stein SC
    Stroke; 2012 Sep; 43(9):2350-5. PubMed ID: 22811451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are some patients likely to benefit from recombinant tissue-type plasminogen activator for acute ischemic stroke even beyond 3 hours from symptom onset?
    Kent DM; Ruthazer R; Selker HP
    Stroke; 2003 Feb; 34(2):464-7. PubMed ID: 12574561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Risk Factors in Thrombolysis therapy: Telestroke Versus Nontelestroke.
    Nathaniel TI; Gainey J; Blum B; Montgomery C; Ervin L; Madeline L
    J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2524-2533. PubMed ID: 29859864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remote or extraischemic intracerebral hemorrhage--an uncommon complication of stroke thrombolysis: results from the safe implementation of treatments in stroke-international stroke thrombolysis register.
    Mazya MV; Ahmed N; Ford GA; Hobohm C; Mikulik R; Nunes AP; Wahlgren N;
    Stroke; 2014 Jun; 45(6):1657-63. PubMed ID: 24788971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The safety and effectiveness of low-dose recombinant tissue plasminogen activator (0.6 mg/kg) therapy for elderly acute ischemic stroke patients (≥ 80 years old) in the pre-endovascular era.
    Takayanagi S; Ochi T; Hanakita S; Suzuki Y; Maeda K
    Neurol Med Chir (Tokyo); 2014 Jun; 54(6):435-40. PubMed ID: 24670312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polyacrylic acid-coated nanoparticles loaded with recombinant tissue plasminogen activator for the treatment of mice with ischemic stroke.
    Huang L; Wang J; Huang S; Siaw-Debrah F; Nyanzu M; Zhuge Q
    Biochem Biophys Res Commun; 2019 Aug; 516(2):565-570. PubMed ID: 31235258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-Acetyl-Seryl-Aspartyl-Lysyl-Proline Augments Thrombolysis of tPA (Tissue-Type Plasminogen Activator) in Aged Rats After Stroke.
    Li C; Zhang L; Wang C; Teng H; Fan B; Chopp M; Zhang ZG
    Stroke; 2019 Sep; 50(9):2547-2554. PubMed ID: 31387512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Memantine improves safety of thrombolysis for stroke.
    Montagne A; Hébert M; Jullienne A; Lesept F; Le Béhot A; Louessard M; Gauberti M; Orset C; Ali C; Agin V; Maubert E; Vivien D
    Stroke; 2012 Oct; 43(10):2774-81. PubMed ID: 22879098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Quinazoline Otaplimastat (SP-8203) Reduces the Hemorrhagic Transformation and Mortality Aggravated after Delayed rtPA-Induced Thrombolysis in Cerebral Ischemia.
    Song HY; Chung JI; Jalin AMA; Ju C; Pahk K; Joung C; Lee S; Jin S; Kim BS; Lee KS; Ryu JM; Kim WK
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. YangXueQingNaoWan attenuated blood brain barrier disruption after thrombolysis with tissue plasminogen activator in ischemia stroke.
    Yao SQ; Ye Y; Li Q; Wang XY; Yan L; Huo XM; Pan CS; Fu Y; Liu J; Han JY
    J Ethnopharmacol; 2024 Jan; 318(Pt B):117024. PubMed ID: 37572928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid breakdown of microvascular barriers and subsequent hemorrhagic transformation after delayed recombinant tissue plasminogen activator treatment in a rat embolic stroke model.
    Dijkhuizen RM; Asahi M; Wu O; Rosen BR; Lo EH
    Stroke; 2002 Aug; 33(8):2100-4. PubMed ID: 12154270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Myocardial Infarction During Intravenous Recombinant Tissue Plasminogen Activator Infusion for Evolving Ischemic Stroke.
    Fitzek S; Fitzek C
    Neurologist; 2015 Sep; 20(3):46-7. PubMed ID: 26375375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
    Seet RC; Rabinstein AA
    Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroserpin extends the time window of tPA thrombolysis in a rat model of middle cerebral artery occlusion.
    Cai L; Zhou Y; Wang Z; Zhu Y
    J Biochem Mol Toxicol; 2020 Nov; 34(11):e22570. PubMed ID: 32659866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion.
    Pfefferkorn T; Rosenberg GA
    Stroke; 2003 Aug; 34(8):2025-30. PubMed ID: 12855824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe renal impairment is associated with symptomatic intracerebral hemorrhage after thrombolysis for ischemic stroke.
    Tütüncü S; Ziegler AM; Scheitz JF; Slowinski T; Rocco A; Endres M; Nolte CH
    Stroke; 2013 Nov; 44(11):3217-9. PubMed ID: 24003042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leukoaraiosis, Cerebral Hemorrhage, and Outcome After Intravenous Thrombolysis for Acute Ischemic Stroke: A Meta-Analysis (v1).
    Charidimou A; Pasi M; Fiorelli M; Shams S; von Kummer R; Pantoni L; Rost N
    Stroke; 2016 Sep; 47(9):2364-72. PubMed ID: 27491738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke.
    Lee KY; Kim DI; Kim SH; Lee SI; Chung HW; Shim YW; Kim SM; Heo JH
    AJNR Am J Neuroradiol; 2004 Oct; 25(9):1470-5. PubMed ID: 15502123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.